vs
EQUITY BANCSHARES INC（EQBK）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
RIGEL PHARMACEUTICALS INC的季度营收约是EQUITY BANCSHARES INC的1.1倍（$69.8M vs $63.5M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs 34.8%，领先349.3%），EQUITY BANCSHARES INC同比增速更快（28.4% vs 21.2%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 6.6%）
繁荣银行股份有限公司是一家银行控股公司，总部位于德克萨斯州休斯顿，业务覆盖德克萨斯州与俄克拉荷马州中部。截至2019年12月末，公司共运营285家分支网点，其中休斯顿地区（含伍德兰兹）65家，南德克萨斯（含科珀斯克里斯蒂、维多利亚）30家，达拉斯-沃斯堡大都会区75家，布局覆盖德克萨斯州各主要区域。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
EQBK vs RIGL — 直观对比
营收规模更大
RIGL
是对方的1.1倍
$63.5M
营收增速更快
EQBK
高出7.2%
21.2%
净利率更高
RIGL
高出349.3%
34.8%
两年增速更快
RIGL
近两年复合增速
6.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $63.5M | $69.8M |
| 净利润 | $22.1M | $268.1M |
| 毛利率 | — | 91.5% |
| 营业利润率 | 41.7% | 33.2% |
| 净利率 | 34.8% | 384.0% |
| 营收同比 | 28.4% | 21.2% |
| 净利润同比 | 30.0% | 1769.2% |
| 每股收益（稀释后） | $1.07 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收EQBKRIGL
| Q4 25 | $63.5M | $69.8M | ||
| Q3 25 | $18.0M | $69.5M | ||
| Q2 25 | $58.4M | $101.7M | ||
| Q1 25 | $60.6M | $53.3M | ||
| Q4 24 | $58.3M | $57.6M | ||
| Q3 24 | $55.3M | $55.3M | ||
| Q2 24 | $55.4M | $36.8M | ||
| Q1 24 | $55.9M | $29.5M |
净利润EQBKRIGL
| Q4 25 | $22.1M | $268.1M | ||
| Q3 25 | $-29.7M | $27.9M | ||
| Q2 25 | $15.3M | $59.6M | ||
| Q1 25 | $15.0M | $11.4M | ||
| Q4 24 | $17.0M | $14.3M | ||
| Q3 24 | $19.9M | $12.4M | ||
| Q2 24 | $11.7M | $-1.0M | ||
| Q1 24 | $14.1M | $-8.2M |
毛利率EQBKRIGL
| Q4 25 | — | 91.5% | ||
| Q3 25 | — | 93.2% | ||
| Q2 25 | — | 95.6% | ||
| Q1 25 | — | 91.7% | ||
| Q4 24 | — | 89.9% | ||
| Q3 24 | — | 85.5% | ||
| Q2 24 | — | 92.4% | ||
| Q1 24 | — | 93.1% |
营业利润率EQBKRIGL
| Q4 25 | 41.7% | 33.2% | ||
| Q3 25 | -207.2% | 40.9% | ||
| Q2 25 | 31.5% | 60.1% | ||
| Q1 25 | 31.1% | 23.9% | ||
| Q4 24 | 35.0% | 28.9% | ||
| Q3 24 | 43.1% | 25.4% | ||
| Q2 24 | 29.4% | 1.2% | ||
| Q1 24 | 31.8% | -23.6% |
净利率EQBKRIGL
| Q4 25 | 34.8% | 384.0% | ||
| Q3 25 | -164.7% | 40.2% | ||
| Q2 25 | 26.1% | 58.6% | ||
| Q1 25 | 24.8% | 21.5% | ||
| Q4 24 | 29.1% | 24.9% | ||
| Q3 24 | 35.9% | 22.5% | ||
| Q2 24 | 21.1% | -2.8% | ||
| Q1 24 | 25.2% | -27.9% |
每股收益（稀释后）EQBKRIGL
| Q4 25 | $1.07 | $14.11 | ||
| Q3 25 | $-1.55 | $1.46 | ||
| Q2 25 | $0.86 | $3.28 | ||
| Q1 25 | $0.85 | $0.63 | ||
| Q4 24 | $1.06 | $0.82 | ||
| Q3 24 | $1.28 | $0.70 | ||
| Q2 24 | $0.76 | $-0.06 | ||
| Q1 24 | $0.90 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $155.0M |
| 总债务越低越好 | $443.2M | $52.5M |
| 股东权益账面价值 | $732.1M | $391.5M |
| 总资产 | $6.4B | $513.6M |
| 负债/权益比越低杠杆越低 | 0.61× | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资EQBKRIGL
| Q4 25 | — | $155.0M | ||
| Q3 25 | — | $137.1M | ||
| Q2 25 | — | $108.4M | ||
| Q1 25 | — | $77.1M | ||
| Q4 24 | — | $77.3M | ||
| Q3 24 | — | $61.1M | ||
| Q2 24 | — | $49.1M | ||
| Q1 24 | — | $49.5M |
总债务EQBKRIGL
| Q4 25 | $443.2M | $52.5M | ||
| Q3 25 | $486.9M | $60.0M | ||
| Q2 25 | $448.4M | $60.0M | ||
| Q1 25 | $376.9M | $60.0M | ||
| Q4 24 | $312.8M | $60.0M | ||
| Q3 24 | $437.5M | $60.0M | ||
| Q2 24 | $391.7M | $60.0M | ||
| Q1 24 | $367.1M | $60.0M |
股东权益EQBKRIGL
| Q4 25 | $732.1M | $391.5M | ||
| Q3 25 | $711.9M | $117.6M | ||
| Q2 25 | $635.6M | $81.9M | ||
| Q1 25 | $617.3M | $18.6M | ||
| Q4 24 | $592.9M | $3.3M | ||
| Q3 24 | $504.0M | $-14.6M | ||
| Q2 24 | $461.4M | $-29.9M | ||
| Q1 24 | $456.8M | $-31.7M |
总资产EQBKRIGL
| Q4 25 | $6.4B | $513.6M | ||
| Q3 25 | $6.4B | $242.5M | ||
| Q2 25 | $5.4B | $206.7M | ||
| Q1 25 | $5.4B | $176.0M | ||
| Q4 24 | $5.3B | $164.0M | ||
| Q3 24 | $5.4B | $139.4M | ||
| Q2 24 | $5.2B | $128.4M | ||
| Q1 24 | $5.2B | $126.5M |
负债/权益比EQBKRIGL
| Q4 25 | 0.61× | 0.13× | ||
| Q3 25 | 0.68× | 0.51× | ||
| Q2 25 | 0.71× | 0.73× | ||
| Q1 25 | 0.61× | 3.23× | ||
| Q4 24 | 0.53× | 18.25× | ||
| Q3 24 | 0.87× | — | ||
| Q2 24 | 0.85× | — | ||
| Q1 24 | 0.80× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $51.4M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $38.1M | — |
| 自由现金流率自由现金流/营收 | 60.0% | — |
| 资本支出强度资本支出/营收 | 20.9% | — |
| 现金转化率经营现金流/净利润 | 2.33× | 0.08× |
| 过去12个月自由现金流最近4个季度 | $88.8M | — |
8季度趋势，按日历期对齐
经营现金流EQBKRIGL
| Q4 25 | $51.4M | $22.0M | ||
| Q3 25 | $8.5M | $24.0M | ||
| Q2 25 | $28.3M | $30.5M | ||
| Q1 25 | $21.7M | $-893.0K | ||
| Q4 24 | $73.8M | $14.5M | ||
| Q3 24 | $23.5M | $21.7M | ||
| Q2 24 | $16.0M | $302.0K | ||
| Q1 24 | $12.6M | $-5.0M |
自由现金流EQBKRIGL
| Q4 25 | $38.1M | — | ||
| Q3 25 | $4.5M | — | ||
| Q2 25 | $26.0M | — | ||
| Q1 25 | $20.2M | — | ||
| Q4 24 | $65.4M | — | ||
| Q3 24 | $19.7M | — | ||
| Q2 24 | $15.2M | — | ||
| Q1 24 | $10.6M | — |
自由现金流率EQBKRIGL
| Q4 25 | 60.0% | — | ||
| Q3 25 | 24.7% | — | ||
| Q2 25 | 44.5% | — | ||
| Q1 25 | 33.3% | — | ||
| Q4 24 | 112.1% | — | ||
| Q3 24 | 35.6% | — | ||
| Q2 24 | 27.4% | — | ||
| Q1 24 | 19.0% | — |
资本支出强度EQBKRIGL
| Q4 25 | 20.9% | — | ||
| Q3 25 | 22.3% | — | ||
| Q2 25 | 3.9% | — | ||
| Q1 25 | 2.4% | — | ||
| Q4 24 | 14.6% | — | ||
| Q3 24 | 6.8% | — | ||
| Q2 24 | 1.5% | — | ||
| Q1 24 | 3.6% | — |
现金转化率EQBKRIGL
| Q4 25 | 2.33× | 0.08× | ||
| Q3 25 | — | 0.86× | ||
| Q2 25 | 1.85× | 0.51× | ||
| Q1 25 | 1.44× | -0.08× | ||
| Q4 24 | 4.35× | 1.01× | ||
| Q3 24 | 1.18× | 1.75× | ||
| Q2 24 | 1.37× | — | ||
| Q1 24 | 0.90× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
